ETIBI DIN 00247960
Status: Marketed
Holder: BAUSCH HEALTH, CANADA INC.
Molecule: ETHAMBUTOL HYDROCHLORIDE
Available to quote
Health Canada record
| Active ingredient(s) | ETHAMBUTOL HYDROCHLORIDE 100 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J04AK02 ETHAMBUTOL |
| Original market date | 31-Dec-1972 |
| Current status date | 10-Jul-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bausch Health Companies Inc. — licence 101880, currently licensed, last inspection rating C (2026-06-01).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ETHAMBUTOL HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00247979 | ETIBI | BAUSCH HEALTH, CANADA INC. | Tablet | ETHAMBUTOL HYDROCHLORIDE 400 MG | Marketed |
| 00127957 | MYAMBUTOL TAB 100MG | LEDERLE CYANAMID CANADA INC. | Tablet | ETHAMBUTOL HYDROCHLORIDE 100 MG | Cancelled Post Market |
| 00127965 | MYAMBUTOL TAB 400MG | LEDERLE CYANAMID CANADA INC. | Tablet | ETHAMBUTOL HYDROCHLORIDE 400 MG | Cancelled Post Market |
| 02170078 | MYAMBUTOL TABLETS - 400 MG | WYETH-AYERST CANADA INC. | Tablet | ETHAMBUTOL HYDROCHLORIDE 400 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22381 | 2019-07-10 | New Drug Submission (NDS) | Administrative: Change in Product Ownership |
| 5558 | 2004-10-12 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
International API supply for ETHAMBUTOL HYDROCHLORIDE
2 valid EDQM Certificates of Suitability from 2 holders. 2 active FDA Drug Master Files.
Request a quote for ETIBI